iRhythm Holdings, Inc. (IRTC)

NasdaqGS · Medical Devices

123.37
-4.43 (-3.47%)
Updated Nov 1, 10:41 PM ET
AI Rating
Hold
Overall Score
61
Trend
47
Momentum
85
Risk
50

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 20, 2025 260 sessions Oct 30, 2026

AI Analysis

iRhythm Holdings, Inc. is trading at $123.37, down 3.47% on the session. The 50 day average sits at $115.04 and the 200 day at $122.38, which puts the stock in a downtrend. RSI is at 63.2, which reads as strong, and MACD is bullish crossover. Volume is above average.

The nearest support is around $115.04 with resistance near $125.86, so that band frames the current range. Average daily movement is roughly $4.42, or about 3.6% of the share price, which is what any stop placement has to allow for. The overall health score of 61 out of 100 combines a trend score of 47, momentum of 85 and a risk score of 50.

Technical indicators

RSI (14)
63.2
strong
MACD
3.347
bullish crossover
SMA 20
113.39
SMA 50
115.04
SMA 200
122.38
downtrend
ATR (14)
4.42
avg daily range
Support
115.04
Resistance
125.86
Volume vs 20d
1.10x
above average
Volatility
37.3%
annualised
1 month
+11.09%
3 months
-1.04%

About iRhythm Holdings, Inc.

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.